171 related articles for article (PubMed ID: 29356898)
1. Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs.
Cusato J; Boglione L; De Nicolò A; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Cantù M; Carcieri C; Cariti G; Di Perri G; D'Avolio A
Cancer Chemother Pharmacol; 2018 Mar; 81(3):615-620. PubMed ID: 29356898
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients.
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A
Infect Genet Evol; 2018 Jun; 60():42-47. PubMed ID: 29452294
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D pathway gene variants and HCV-2/3 therapy outcomes.
Cusato J; Allegra S; Boglione L; De Nicolò A; Baietto L; Cariti G; Di Perri G; D'Avolio A
Antivir Ther; 2015; 20(3):335-41. PubMed ID: 25279449
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemia.
Cusato J; Boglione L; De Nicolò A; Cardellino CS; Carcieri C; Cariti G; Di Perri G; D'Avolio A
Pharmacogenet Genomics; 2016 Jun; 26(6):307-10. PubMed ID: 27139837
[TBL] [Abstract][Full Text] [Related]
5. Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development.
Lange CM; Miki D; Ochi H; Nischalke HD; Bojunga J; Bibert S; Morikawa K; Gouttenoire J; Cerny A; Dufour JF; Gorgievski-Hrisoho M; Heim MH; Malinverni R; Müllhaupt B; Negro F; Semela D; Kutalik Z; Müller T; Spengler U; Berg T; Chayama K; Moradpour D; Bochud PY; ;
PLoS One; 2013; 8(5):e64053. PubMed ID: 23734184
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor rs3782905 and vitamin D binding protein rs7041 polymorphisms are associated with hepatocellular carcinoma susceptibility in cirrhotic HCV patients.
El-Masry AS; Medhat AM; El-Bendary M; Mohamed RH
BMC Med Genomics; 2023 Dec; 16(1):319. PubMed ID: 38066559
[TBL] [Abstract][Full Text] [Related]
7. Role of
Barooah P; Saikia S; Bharadwaj R; Sarmah P; Bhattacharyya M; Goswami B; Medhi S
Genet Test Mol Biomarkers; 2019 May; 23(5):325-331. PubMed ID: 30942619
[No Abstract] [Full Text] [Related]
8. Influence of vitamin D-related gene polymorphisms (CYP27B and VDR) on the response to interferon/ribavirin therapy in chronic hepatitis C.
García-Martín E; Agúndez JA; Maestro ML; Suárez A; Vidaurreta M; Martínez C; Fernández-Pérez C; Ortega L; Ladero JM
PLoS One; 2013; 8(9):e74764. PubMed ID: 24073221
[TBL] [Abstract][Full Text] [Related]
9. Direct Relationship between Interleukin-10 Gene Polymorphism and Hepatocellular Carcinoma Complicated by Direct Acting Antiviral Treatment of Hepatitis C Virus.
Ghanm SE; Shebl NA; El Sayed IET; Abdel-Bary HM; Saad BF; Othman Saad W
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3203-3210. PubMed ID: 34710996
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.
Wu X; Cheng J; Yang K
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669215
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy.
Lange CM; Bojunga J; Ramos-Lopez E; von Wagner M; Hassler A; Vermehren J; Herrmann E; Badenhoop K; Zeuzem S; Sarrazin C
J Hepatol; 2011 May; 54(5):887-93. PubMed ID: 21145801
[TBL] [Abstract][Full Text] [Related]
12. The associated ion between the VDR gene polymorphisms and susceptibility to hepatocellular carcinoma and the clinicopathological features in subjects infected with HBV.
Yao X; Zeng H; Zhang G; Zhou W; Yan Q; Dai L; Wang X
Biomed Res Int; 2013; 2013():953974. PubMed ID: 23586065
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals.
Prenner SB; VanWagner LB; Flamm SL; Salem R; Lewandowski RJ; Kulik L
J Hepatol; 2017 Jun; 66(6):1173-1181. PubMed ID: 28161470
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants underlying vitamin D metabolism and VDR-TGFβ-1-SMAD3 interaction may impact on HCV progression: a study based on dbGaP data from the HALT-C study.
de Azevedo LA; Matte U; da Silveira TR; Álvares-da-Silva MR
J Hum Genet; 2017 Nov; 62(11):969-977. PubMed ID: 28703134
[TBL] [Abstract][Full Text] [Related]
15. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients.
Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P
BMC Gastroenterol; 2017 Apr; 17(1):54. PubMed ID: 28415985
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of vitamin D receptor (VDR), CYP27B1 and CYP24A1 genes and the risk of colorectal cancer.
Vidigal VM; Silva TD; de Oliveira J; Pimenta CAM; Felipe AV; Forones NM
Int J Biol Markers; 2017 May; 32(2):e224-e230. PubMed ID: 28009432
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes.
Gal-Tanamy M; Bachmetov L; Ravid A; Koren R; Erman A; Tur-Kaspa R; Zemel R
Hepatology; 2011 Nov; 54(5):1570-9. PubMed ID: 21793032
[TBL] [Abstract][Full Text] [Related]
19. Apa1 (rs7975232) SNP in the vitamin D receptor is linked to hepatocellular carcinoma in hepatitis C virus cirrhosis.
Raafat Rowida I; Eshra KA; El-Sharaby RM; Eissa R; Saied SM; Amer I; El Sharawy S
Br J Biomed Sci; 2020 Apr; 77(2):53-57. PubMed ID: 31682785
[No Abstract] [Full Text] [Related]
20. lnc-HOTAIR predicts hepatocellular carcinoma in chronic hepatitis C genotype 4 following direct-acting antivirals therapy.
El-Khazragy N; Elshimy AA; Hassan SS; Shaaban MH; Bayoumi AH; El Magdoub HM; Ghozy S; Gaballah A; Aboelhussein MM; Abou Gabal HH; Bannunah AM; Mansy AE
Mol Carcinog; 2020 Dec; 59(12):1382-1391. PubMed ID: 33074585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
